A Call for Better Guidance and Treatments for Comorbid Postpartum Depression and Substance Use Disorders

Postpartum depression is a serious, but treatable condition experienced after childbirth. While most cases do not involve excess substance use, alcohol and other substance use have been strongly associated with this condition. While serotonergic antidepressants have been a mainstay of pharmacologic therapy for postpartum depression, studies of antidepressant use in postpartum depression have largely excluded those with substance use disorder, and meta-analyses suggest antidepressants offer limited benefit in those with depression and co-occurring substance use disorder. There is also under-appreciated literature demonstrating the potential for a medication-mediated increase in substance use in some individuals taking serotonergic antidepressants. These facts and an examination of guideline recommendations on the treatment for postpartum depression highlight the need for new research and practice improvements for patients with comorbid substance use disorder and postpartum depression.

Authors

Institutions

Publication Details

Journal
Journal of Addiction Medicine
Published
2025-03-05
DOI
https://doi.org/10.1097/adm.0000000000001475
Citations
1
Primary Topic
Maternal Mental Health During Pregnancy and Postpartum
Type
article
Field-Weighted Citation Impact
1.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Call for Better Guidance and Treatments for Comorbid Postpartum Depression and Substance Use Disorders

Jeffrey Pan, Kevin Y. Xu, Evan Wood
1 citations
Journal of Addiction Medicine
Maternal Mental Health During Pregnancy and Postpartum
1.88
article

A Call for Better Guidance and Treatments for Comorbid Postpartum Depression and Substance Use Disorders

Jeffrey Pan, Kevin Y. Xu, Evan Wood
article en
1 citations

Abstract

Postpartum depression is a serious, but treatable condition experienced after childbirth. While most cases do not involve excess substance use, alcohol and other substance use have been strongly associated with this condition. While serotonergic antidepressants have been a mainstay of pharmacologic therapy for postpartum depression, studies of antidepressant use in postpartum depression have largely excluded those with substance use disorder, and meta-analyses suggest antidepressants offer limited benefit in those with depression and co-occurring substance use disorder. There is also under-appreciated literature demonstrating the potential for a medication-mediated increase in substance use in some individuals taking serotonergic antidepressants. These facts and an examination of guideline recommendations on the treatment for postpartum depression highlight the need for new research and practice improvements for patients with comorbid substance use disorder and postpartum depression.

Journal of Addiction MedicineVol. 19(6)
University of British Columbia (CA), Washington University in St. Louis (US), British Columbia Centre on Substance Use (CA)
National Institutes of Health, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 18%
Maternal Mental Health During Pregnancy and Postpartum
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.